926 related articles for article (PubMed ID: 11274752)
1. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
2. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
Senthilkumar M; Mishra P; Jain NK
J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
[TBL] [Abstract][Full Text] [Related]
3. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
4. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
Gajendiran M; Divakar S; Raaman N; Balasubramanian S
Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139
[TBL] [Abstract][Full Text] [Related]
5. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
Duan Y; Sun X; Gong T; Wang Q; Zhang Z
J Mater Sci Mater Med; 2006 Jun; 17(6):509-16. PubMed ID: 16691348
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of three-arm block copolymer poly(lactic-
Zhu X; Liu C; Duan J; Liang X; Li X; Sun H; Kong D; Yang J
Int J Nanomedicine; 2016; 11():6065-6077. PubMed ID: 27895480
[TBL] [Abstract][Full Text] [Related]
8. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers.
Beletsi A; Panagi Z; Avgoustakis K
Int J Pharm; 2005 Jul; 298(1):233-41. PubMed ID: 15936907
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
[TBL] [Abstract][Full Text] [Related]
11. Self-assembled nanomicelles using PLGA-PEG amphiphilic block copolymer for insulin delivery: a physicochemical investigation and determination of CMC values.
Ashjari M; Khoee S; Mahdavian AR; Rahmatolahzadeh R
J Mater Sci Mater Med; 2012 Apr; 23(4):943-53. PubMed ID: 22354326
[TBL] [Abstract][Full Text] [Related]
12. In vitro study and characterization of doxorubicin-loaded magnetic nanoparticles modified with biodegradable copolymers.
Ebrahimi E; Khandaghi AA; Valipour F; Babaie S; Asghari F; Motaali S; Abbasi E; Akbarzadeh A; Davaran S
Artif Cells Nanomed Biotechnol; 2016; 44(2):550-8. PubMed ID: 25345419
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
14. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles.
Panagi Z; Beletsi A; Evangelatos G; Livaniou E; Ithakissios DS; Avgoustakis K
Int J Pharm; 2001 Jun; 221(1-2):143-52. PubMed ID: 11397575
[TBL] [Abstract][Full Text] [Related]
15. Nanoscale cationic micelles of amphiphilic copolymers based on star-shaped PLGA and PEI cross-linked PEG for protein delivery application.
Wang J; Li S; Chen T; Xian W; Zhang H; Wu L; Zhu W; Zeng Q
J Mater Sci Mater Med; 2019 Aug; 30(8):93. PubMed ID: 31392433
[TBL] [Abstract][Full Text] [Related]
16. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
Kwon YM; Kim SW
Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.
Song Z; Feng R; Sun M; Guo C; Gao Y; Li L; Zhai G
J Colloid Interface Sci; 2011 Feb; 354(1):116-23. PubMed ID: 21044788
[TBL] [Abstract][Full Text] [Related]
19. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
Gullotti E; Park J; Yeo Y
Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560
[TBL] [Abstract][Full Text] [Related]
20. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
